Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darrell A Henze

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Plos One|April 16, 2025
Multi-omics profiles of chronic low back pain and fibromyalgia-Study protocolMichele Curatolo, Abby P Chiu, Catherine Chia, et al.
Molecular Pain|October 29, 2008
HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivitySamer R Eid, Eric D Crown, Eric L Moore, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2014
Benzimidazole CB2 agonists: design, synthesis and SARKausik K Nanda, Darrell A Henze, Kimberly Della Penna, et al.
Frontiers in Pharmacology|January 10, 2022
Translational Pharmacokinetic-Pharmacodynamic Modeling of NaV1.7 Inhibitor MK-2075 to Inform Human Efficacious DoseJeanine E Ballard, Parul S Pall, Joshua Vardigan, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2011
High concentration electrophysiology-based fragment screen: discovery of novel acid-sensing ion channel 3 (ASIC3) inhibitorsScott E Wolkenberg, Zhijian Zhao, James J Mulhearn, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Spatial transcriptomic profiling of human paravertebral sympathetic chain ganglia reveals diabetes-induced neuroplasticityMarisol Mancilla Moreno, Pooja J Patel, Kree Goss, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2011
Decahydroquinoline amides as highly selective CB2 agonists: role of selectivity on in vivo efficacy in a rodent model of analgesiaPeter J Manley, Amy Zartman, Daniel V Paone, et al.
Neurobiology of Pain (Cambridge, Mass.)|April 11, 2025
Humanized Na<sub>V</sub>1.8 rats overcome cross-species potency shifts in developing novel Na<sub>V</sub>1.8 inhibitorsDillon S McDevitt, Joshua D Vardigan, Xiaoping Zhou, et al.
Science Translational Medicine|May 20, 2021
Na<sub>v</sub>1.7 target modulation and efficacy can be measured in nonhuman primate assaysRichard L Kraus, Fuqiang Zhao, Parul S Pall, et al.
Pain|October 9, 2024
Analgesia and peripheral c-fiber modulation by selective Na v 1.8 inhibition in rhesusJoshua D Vardigan, Parul S Pall, Dillon S McDevitt, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Plos One|April 16, 2025
Multi-omics profiles of chronic low back pain and fibromyalgia-Study protocolMichele Curatolo, Abby P Chiu, Catherine Chia, et al.
Molecular Pain|October 29, 2008
HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivitySamer R Eid, Eric D Crown, Eric L Moore, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2014
Benzimidazole CB2 agonists: design, synthesis and SARKausik K Nanda, Darrell A Henze, Kimberly Della Penna, et al.
Frontiers in Pharmacology|January 10, 2022
Translational Pharmacokinetic-Pharmacodynamic Modeling of NaV1.7 Inhibitor MK-2075 to Inform Human Efficacious DoseJeanine E Ballard, Parul S Pall, Joshua Vardigan, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2011
High concentration electrophysiology-based fragment screen: discovery of novel acid-sensing ion channel 3 (ASIC3) inhibitorsScott E Wolkenberg, Zhijian Zhao, James J Mulhearn, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Spatial transcriptomic profiling of human paravertebral sympathetic chain ganglia reveals diabetes-induced neuroplasticityMarisol Mancilla Moreno, Pooja J Patel, Kree Goss, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2011
Decahydroquinoline amides as highly selective CB2 agonists: role of selectivity on in vivo efficacy in a rodent model of analgesiaPeter J Manley, Amy Zartman, Daniel V Paone, et al.
Neurobiology of Pain (Cambridge, Mass.)|April 11, 2025
Humanized Na<sub>V</sub>1.8 rats overcome cross-species potency shifts in developing novel Na<sub>V</sub>1.8 inhibitorsDillon S McDevitt, Joshua D Vardigan, Xiaoping Zhou, et al.
Science Translational Medicine|May 20, 2021
Na<sub>v</sub>1.7 target modulation and efficacy can be measured in nonhuman primate assaysRichard L Kraus, Fuqiang Zhao, Parul S Pall, et al.
Pain|October 9, 2024
Analgesia and peripheral c-fiber modulation by selective Na v 1.8 inhibition in rhesusJoshua D Vardigan, Parul S Pall, Dillon S McDevitt, et al.
Pageof 4